April didn’t bring the kind of market performance we’ve come to expect. Instead of historical gains, investors were met with ...

Biotech advancements often face delays due to bureaucracy, hindering the development of necessary therapies. Now is the time ...

RiskHedge helps investors profit from disruption by providing research on the latest breakthrough technologies and the stocks ...

Mergers and acquisitions are a popular target of economic populists on the left and right. Populists blame mergers for ...

Do we need to redefine “value” in this era of the US stock market, or should we continue to sit on the sidelines if ...

In his forum lead, Charles T. Rubin worries that turning human governance over to artificial general intelligence (AGI) will cause immense problems. The world, in particular the United States, has man ...

In recent days, headlines have screamed of economic doom. Yet our RealClearMarkets/TIPP survey tells a more grounded story: ...

I attended the Goldman Sachs shareholder meeting as a representative of the National Center for Public Policy Research (I’m ...

H, I learned the fable of the Wise Man, The Young Boy, and The Little Bird. In the story, a young boy plans to trick a wise ...

Every year leading up to Tax Day, Americans face a familiar and frustrating ritual: sorting through receipts, deciphering forms, clicking through software prompts, and hoping they haven’t made a ...

He may still turn things around, but it’s a shame about President Trump and the economy. All he had to do was nothing, and what they refer to as ...

The Department of Justice has successfully prosecuted Google in two recent antitrust suits, aiming to break up the tech giant ...